A $23,000 “Quantum Biology” Plan Claimed to Scientifically Treat COVID-19, Cancer, and Parkinson's

Golden Sunrise Nutraceutical, Inc. described itself as a pharmaceutical and “nutraceutical” company developing dietary supplements using principles the company called “quantum biology.” Between July 2017 and July 2020, the company sold treatment plans marketed with names like the Primary Plan of Care, the Emergency D-Virus Plan of Care, the Metabolic Plan of Care, and the Cancer Plan of Care, some costing as much as $23,000. According to the Federal Trade Commission, those plans were marketed as scientifically proven treatments for COVID-19, cancer, and Parkinson's disease — despite being made mostly of herbs and spices.DOCUMENTED

The company's medical director, Dr. Stephen Meis, agreed in June 2021 to settle FTC charges, and a federal court later entered summary judgment against the remaining corporate defendants and an additional officer in September 2025. Refunds to affected consumers have continued as recently as February 2026.DOCUMENTED

What the complaint alleges

According to the FTC, Golden Sunrise marketed its treatment plans using claims that they were scientifically proven to treat serious, specific diseases — COVID-19, cancer, and Parkinson's disease — despite lacking the kind of competent and reliable clinical evidence federal law requires before making disease-treatment claims of this magnitude.DOCUMENTED The underlying products were composed largely of herbs and spices, framed by the company's “quantum biology” branding as scientifically sophisticated formulations, even though the complaint alleges no genuine clinical evidence supported the specific disease claims attached to them.DOCUMENTED

Why the $23,000 COVID plan drew particular attention

Marketing a $23,000 treatment plan as a scientifically proven COVID-19 cure, during a period of widespread public fear and scientific uncertainty about the virus, represents one of the more serious individual claims within the FTC's broader wave of pandemic-era health fraud enforcement — both for its price point and for the specificity of the medical claim attached to a product with no established clinical basis for treating a novel, actively spreading virus.REVIEWED A consumer paying that sum based on a belief the product was scientifically validated faced not only significant financial loss but also the risk of forgoing evidence-based medical care during an active infection.

Why the case eventually included criminal charges

Beyond the FTC's civil enforcement action, Golden Sunrise's false advertising ultimately led to separate criminal charges against one of its officers, who was later sentenced to federal prison in connection with the underlying conduct.DOCUMENTED That criminal referral reflects how a health-claims case involving a demonstrably fabricated cure for a serious, actively dangerous disease can escalate beyond the civil penalties and consumer redress typical of most FTC advertising-substantiation cases, when the underlying conduct rises to the level prosecutors determine warrants criminal charges.

How the case proceeded in stages

The FTC first resolved its claims against medical director Dr. Stephen Meis in June 2021, barring him from making similar unsupported health claims and requiring him to pay $103,420 toward consumer refunds.DOCUMENTED Litigation continued against the remaining corporate defendants and additional officer Huu Tieu for several more years, with a federal court in the Eastern District of California entering summary judgment in the FTC's favor in September 2025, permanently barring the remaining defendants from making unsupported health claims as well.DOCUMENTED

Terms of the settlement and ongoing refunds

The FTC began mailing refund claim forms to the 581 consumers eligible for compensation in January 2025, more than four years after the original order against Meis, using the $103,420 he was required to pay.DOCUMENTED In February 2026, the agency sent 578 checks totaling more than $40,700 to consumers who filed valid claims — a modest per-consumer amount reflecting how the available settlement funds were divided across the full group of eligible purchasers.DOCUMENTED

The products were made primarily of herbs and spices, marketed under a “quantum biology” framing as scientifically proven treatments for COVID-19, cancer, and Parkinson's disease.

Why the case matters

For consumers evaluating any health product marketed with sophisticated-sounding scientific branding — “quantum biology” among them — the Golden Sunrise case is a reminder that specialized-sounding terminology is not itself evidence of clinical validity, and that a product claiming to scientifically treat a serious, named disease deserves the same scrutiny of its actual supporting evidence regardless of how technical or credible the surrounding marketing language sounds.

Why the criminal referral set this case apart

Most FTC health-claims cases resolve entirely through civil settlements, without any accompanying criminal prosecution, since the agency's own authority is limited to civil penalties and consumer redress rather than criminal charges. The escalation to criminal prosecution against a Golden Sunrise officer reflects how egregious, and how directly tied to potential physical harm, regulators and prosecutors judged the underlying conduct to be, given that the false claims specifically targeted people confronting an active, dangerous, and at the time poorly understood viral pandemic.

What patients can ask before trusting an alternative treatment claim

Patients considering any product marketed as a scientifically proven treatment for a serious disease can ask the seller to name the specific peer-reviewed clinical trials supporting that claim, and can independently search for those trials through public medical research databases before paying. A company that cannot or will not provide that information, no matter how sophisticated its underlying branding sounds, is asking for trust the Golden Sunrise case shows was not warranted. Scientific-sounding branding is not a substitute for that kind of verifiable evidence, however confidently it is presented.

Have documents relevant to this story? Reach us through our tips channel.